Inactive Instrument
Stemcell Holdings, Inc. Share Price Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 24/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 16.43L | |
| +0.36% | +0.44% | +17.06% | -12.80% | 6.34TCr | |
| -1.56% | +1.14% | +54.57% | +224.32% | 5.7TCr | |
| +0.36% | +39.60% | +39.60% | +39.60% | 4.16TCr | |
| +3.16% | +5.65% | -50.57% | -57.33% | 3.8TCr | |
| -2.59% | +5.51% | +61.90% | -26.22% | 3.19TCr | |
| +2.92% | +18.67% | +149.91% | -41.10% | 2.78TCr | |
| +0.34% | +5.23% | +66.06% | +83.84% | 2.26TCr | |
| -0.56% | +4.05% | +1.53% | +168.92% | 1.76TCr | |
| +1.34% | -0.64% | +64.17% | +124.88% | 1.65TCr | |
| Average | +0.33% | +5.13% | +44.91% | +56.01% | 3.52TCr | |
| Weighted average by Cap. | +0.24% | +4.50% | +39.93% | +51.81% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 33.39L 29.31L 26.98L 25.14L 47.42L 32Cr 48.38L 3.25Cr 1.26Cr 16Cr 1.25Cr 1.23Cr 54Cr | 61.8L 54.26L 49.94L 46.54L 87.77L 59Cr 89.55L 6.01Cr 2.33Cr 29Cr 2.32Cr 2.27Cr 100.37Cr |
| Net income | 14.02L 12.31L 11.33L 10.56L 19.92L 13Cr 20.32L 1.36Cr 52.82L 6.54Cr 52.66L 51.52L 23Cr | 24.1L 21.16L 19.47L 18.15L 34.22L 23Cr 34.92L 2.34Cr 90.75L 11Cr 90.48L 88.52L 39Cr |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
